Ki-67 As A Prognostic Factor In Breast Cancer Women Receiving Neoadjuvant Dose Dense Chemotherapy AC x 4 Cycles Followed By Paclitaxel x 4 Cycles

Ahmed Mohamed Gaballah;

Abstract


The study included fifty (50) eligible female patients with breast cancer either in early or locally advanced stages not operated and did not receive any prior chemotherapy, radiotherapy or hormonal treatment for breast cancer.
Patients’ age were ranged

Other data

Title Ki-67 As A Prognostic Factor In Breast Cancer Women Receiving Neoadjuvant Dose Dense Chemotherapy AC x 4 Cycles Followed By Paclitaxel x 4 Cycles
Other Titles دزاصخ أه خًُ اندن مُ Ki-67 ف رق ىُُ يسض صسطب انثد انر زَهقى جسعبد يكثفخ ي اندوكضىزوثض و انض كُهىفىصفبي دُ لازثع جسعبد هَ هُب انجبكه زُبكض مُ لازثع جسعبد علاج ب ك بًُو ب قجم
Authors Ahmed Mohamed Gaballah
Keywords Ki-67 As A Prognostic Factor In Breast Cancer Women Receiving Neoadjuvant Dose Dense Chemotherapy AC x 4 Cycles Followed By Paclitaxel x 4 Cycles
Issue Date 2013
Description 
The study included fifty (50) eligible female patients with breast cancer either in early or locally advanced stages not operated and did not receive any prior chemotherapy, radiotherapy or hormonal treatment for breast cancer.
Patients’ age were ranged

Attached Files

File SizeFormat
114200ahmed.pdf433.04 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar
Ki-67 As A Prognostic Factor In Breast Cancer Women Receiving Neoadjuvant Dose Dense Chemotherapy AC x 4 Cycles Followed By Paclitaxel x 4 Cycles


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.